Last reviewed · How we verify
Randomized Controlled Trial To Evaluate Efficacy And Safety Of The Polyvalent Anti-scorpion Venom Serum Of Birmex Versus Other Commercial Venom Serum In Children Population
The morbidity associated with scorpion sting intoxication presents an endemic pattern in the country, where there are highly venomous species of scorpions so the scorpion sting intoxication (IPPA) is considered a medical emergency. On the other hand, there is scarce scientific literature from different controlled studies evaluating anti-scorpion serum, considering clinical severity scales, lab results and their safety. The aim of this study is to compare the efficacy and safety of scorpion sting treatment, using two sera, one produced by Birmex versus Alacramyn ® (Bioclon).
Details
| Lead sponsor | Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 120 |
| Start date | 2011-08 |
| Completion | 2012-05 |
Conditions
- Scorpion Sting
Interventions
- Anti-scorpion venom serum Birmex
- Anti-scorpion venom serum Alacramyn
Primary outcomes
- Resolution of signs and symptoms of scorpion envenomation — after treatment (expected average of 12 hrs)
Countries
Mexico